Patricia Harris - Concepedia

Author

Patricia Harris

Houston Methodist

Also Known As

P Harris, P. Harris, P. W. Harris, Patricia Harris, Patricia W. Harris

Publications

309

Citations

H-Index

Concepts

All Affiliations

Houston Methodist Yale University The University of Texas MD Anderson Cancer Center

About

Patricia Harris is an author at Houston Methodist specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	213
2	Health Sciences	2	2	101
3	Public Health	1	1	61
4	Diagnostic Sciences	1	1	85
5	Emergency Medicine	1	1	29

Patricia Harris

Publications

292

Citations

H-Index

Page 1

	Year	Citations
A phase II trial of intra-patient dose-escalated sorafenib in patients (pts) with metastatic renal cell cancer (MRCC) R. J. Amato, Patricia Harris, Martin L. Dalton, Journal of Clinical Oncology Therapeutic Drug MonitoringIntra-patient Dose-escalated SorafenibUrologyPhase Ii TrialGenitourinary Cancer	2007	85
Hysterosalpingo-contrast sonography (HyCoSy) using Echovist®-200 in the outpatient investigation of infertility patients Gubby Ayida, Patricia Harris, Stephen Kennedy, British Journal of Radiology HysteroscopyHysterosalpingo-contrast SonographyMedical UltrasoundFertilityReproductive Health	1996	61
Predicting Cellular Rejection With a Cell-Based Assay Chethan Ashokkumar, Kyle Soltys, George Mazariegos, Transplantation	2016	37
Outcomes before and after initiation of an acute aortic treatment center Mark G. Davies, Houssam Younes, Patricia Harris, Journal of Vascular Surgery Cardiovascular DiseaseAcute CarePatient SafetyVascular SurgeryOutcomes Research	2010	29
Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia Ian W. Flinn, Manish R. Patel, Brad S. Kahl, Blood	2013	28
Thoracic Endovascular Aortic Repair for Type B Aortic Dissection Houssam Younes, Patricia Harris, Jean Bismuth, Annals of Vascular Surgery Endovascular TechniqueVascular SurgeryThoracic SurgerySurgeryEndovascular Management	2009	22
Bosutinib (BOS) versus imatinib (IM) in patients (pts) with chronic phase chronic myeloid leukemia (CP CML) in the BELA trial: 18-month follow-up. Carlo Gambacorti‐Passerini, Jörge E. Cortes, D. Kim, Journal of Clinical Oncology Hematological MalignancyHealth SciencesVersus ImatinibNovel TherapyMedicine	2011	16
A Phase 1 Study of ACTR087 in Combination with Rituximab, in Subjects with Relapsed or Refractory CD20-Positive B-Cell Lymphoma Javier Muñoz, Samantha Jaglowski, Matthew McKinney, Blood	2019	14

Page 1